Behavioral assessment and treatment for children with Cornelia de Lange Syndrome
Official title: Behavioral Assessment and Treatment of Problem Behavior in Children With Cornelia de Lange Syndrome
Run by Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · NCT05829668 · Data updated 2026-11-12
This study is trying to find out what causes problem behaviors in children with Cornelia de Lange Syndrome and test new ways to help reduce those behaviors.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 3 Years to 15 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | August 2, 2023 |
| Main results expected | August 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | October 29, 2025 |
| Trial ID | NCT05829668 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking children aged 3 to 15 years with a clinical diagnosis of CdLS who exhibit problem behaviors.
✕Probably not a fit
Patients who do not exhibit problem behaviors or are outside the age range of 3 to 15 years may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to identify factors contributing to problem behaviors in children with Cornelia de Lange Syndrome (CdLS) and develop effective behavioral assessment and treatment models. The study will utilize applied behavior analysis (ABA) techniques, including functional analysis, to understand the triggers of problem behaviors such as self-injury and aggression. Participants will include children aged 3 to 15 years with CdLS, both those exhibiting problem behaviors and those without, to compare outcomes and refine treatment strategies. The goal is to reduce problem behaviors by 80% or more through tailored interventions.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life for children with CdLS by reducing harmful behaviors and enhancing their ability to communicate and interact.
How similar studies have gone: While there is limited literature on functional analysis of problem behavior in CdLS, previous studies in related populations have shown promising results using similar ABA-based approaches.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for treatment group: 1. Child with CdLS and problem behavior: 1. clinical diagnosis of CdLS confirmed; 2. age 3 to 15 years; 3. is English-speaking; 4. exhibits SIB, aggression, and/or disruptive behavior; and 5. is able to participate in several hours of assessment/treatment. 2. Parent of child with CdLS is English-speaking and is willing to: 1. attend 2 full-day and one half-day clinic visits; 2. complete and return study measures; and 3. implement a behavior plan. Inclusion Criteria for control group: 1. Child with CdLS without problem behavior: 1. clinical diagnosis of CdLS confirmed; 2. is English-speaking 3. age 3 to 15 years; and 4. child's age and adaptive functioning level matches that of a child in the treatment group 2. Parent of child with CdLS is English-speaking and willing to: 1. complete and return study measures. Exclusion Criteria for treatment group: 1. Child with CdLS: 1. does not exhibit SIB, aggression, or disruptive behavior; 2. child is younger than 3 years or older than 15 years; 3. is not English-speaking; 4. has severe SIB that produces significant tissue damage or requires protective equipment; 5. has uncontrolled seizures; or 6. has medical conditions or requires time-intensive medical care that limits attendance or participation. 2. Parent of child with CdLS is not English-speaking or is not willing to complete study procedures. Exclusion Criteria for the control group: 1. Child with CdLS: 1. exhibits SIB, aggression, or disruptive behavior; 2. is younger than 3 years or older than 15 years; 3. is not English-speaking; 4. age and adaptive functioning level do not match that of a child in the treatment group. 2. Parent of child with CdLS is not English-speaking or willing to complete study procedures.
Where it's running
-
Kennedy Krieger Institute
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Patricia F Kurtz, PhD — Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Study coordinator: Patricia F Kurtz, PhD
- Email: kurtz@kennedykrieger.org
- Phone: 443-923-2894
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating the effects of lithium treatment in Cornelia De Lange Syndrome
This study is testing if lithium treatment can help improve behavior, communication, thinking skills, and sleep in kids and adults with Cornelia De Lange Syndrome.
-
Observing the health management of patients with rare genetic syndromes
This study looks at how patients with rare genetic syndromes like Prader-Willi and Klinefelter manage their health as they move from children's care to adult care to see what support they need.
-
Registry for patients with rare diseases
This study is creating a central registry for people with rare diseases to help connect them with researchers and improve treatments.
-
Inclusive physical activity program for adults with intellectual disabilities
This study is testing a new fitness program for adults with intellectual disabilities to see if it helps them be more active and feel better over 16 weeks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.